Viewing Study NCT00311220



Ignite Creation Date: 2024-05-05 @ 4:48 PM
Last Modification Date: 2024-10-26 @ 9:24 AM
Study NCT ID: NCT00311220
Status: UNKNOWN
Last Update Posted: 2006-04-05
First Post: 2006-04-03

Brief Title: Use TST and QFT-RD1 Test to Monitor the Tuberculous Infection in Patients Close Contact People and Health Care Workers
Sponsor: Taichung Veterans General Hospital
Organization: Taichung Veterans General Hospital

Study Overview

Official Title: Phase IV Study of the Quantiferon-RD1 Test
Status: UNKNOWN
Status Verified Date: 2006-04
Last Known Status: RECRUITING
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: Tuberculosis is still the most common infectious disease in Taiwan The infants in Taiwan have been vaccinated at birth with BCG -Tokyo 171 strain since 1951 The BCG vaccination rate is 97 among first grade students in a recent national survey Even with such a high BCG vaccination coverage Taiwan still has a relatively high TB incidence rate In 2004 there were totally 16784 newly diagnosed TB cases and the annual incidence was 7411 per 100000 population nationally Nearly 70 of the incidence cases were men and 304 were women The mean age of incidence cases was 578 years old median63 84405029 patients were elderly than 65 years old The elderly men did not receive the BCG vaccination and were the most important group to develop newly diagnosed tuberculosis and a special issue for the national TB control program in Taiwan

The tuberculin skin test TST is the only widely available method for detecting whether people have an immunologic reactivity to mycobacterial antigens and identified as latent tuberculosis infection LTBI Targeted tuberculin testing for latent TB infection is a very important strategy to identify subjects with high risk to develop tuberculosis including those who have recent infection with Mycobacterium tuberculosis or have clinical conditions that associated with an increased risk for progression of LTBI to active TB but the sensitivity was lower in elderly patients

Quantiferon-TB gold test QFT-RD1 is a new diagnostic test for latent tuberculosis and a valuable alternative to skin testing This whole-blood assay measures the production of IFN- in whole blood upon stimulation by ESAT-6 and CFP-10 and allows distinction of latent M tuberculosis infection from BCG-induced reactivity ESAT-6 and CFP-10 are deleted from BCG Region 1 RD1 not present in most nontuberculous mycobacteria and are highly specific indicators of M tuberculosis infection Thus the aim of this study was to estimate the specificity and sensitivity of a whole blood IFN-γassay employing CFP-10 and ESAT-6 for the detection of M tuberculosis infection in a clustered high risk elderly population

Changhwa Veterans Home is a government-expense veterans home with totally 519 residents in 2004The inhabitants were all elderly people and lived in groups They did not receive BCG vaccination and were the high risk group to develop endemic TB infection The annual TB incidence rate over there was 3500 per 100000 population
Detailed Description: STUDY POPULATION AND METHODS Population The study population represented individuals screened for TB over a 6-month period ending in December 2004 as part of a number of community health outreach programs based at the Center of Disease Control in Taichung Taiwan Changhwa Veterans Home is a government-expense veterans home with totally 519 residents in 2004 Only individuals with a properly read TST and signed informed consent were included in the study population If a TST was positive further evaluation for TB was advised Anyone found to have active TB infection 12 individuals diagnosed all from household contacts was appropriately treated and were also included from the study No general population low-risk controls were included in the study population There were no other entry exclusions for the study Before the TST was administered a short interview including verbal consent and a BCG scar count evaluation was conducted by an experienced nurse

The TST contained 2 tuberculin units TU of RT23 tuberculin with Tween 80 02 ml of 1TU01 ml given intradermally on the left forearm volar surface by Mantoux technique Validity measures such as inter-observer performance were done for TST placement or interpretation individually by two experienced nurse A purified protein derivative-Siebert PPD-S dose of 5TU is roughly equivalent to the 2TU of RT23 2TU is the International Union Against Tuberculosis and Lung Disease recommended dose for RT23 TST TST was also performed on BCG-vaccinated health care workers After 48-72 h of injection the TST site should be evaluated for induration and a transverse measurement was recorded Any readings made outside of the above time period were excluded from the study All unvaccinated subjects had their blood drawn for the QFT-RD1 the same time with applying the first TST A TST reaction size of 10 mm was interpreted as a positive TST which guided any further medical evaluation This is the traditional cutoff point used for RT23 tuberculin in Taiwan as well as in most studies worldwide If initial TST diameter less than 10 mm second TST was repeated within 1-5 weeks to observe any boosting phenomenon was possible Statistical analysis of skin test results for each population characteristic was done at this cut-off point with the exception of one analysis specifically done at18 mm in BCG-vaccinated health care workers

Household contacts of active TB patients were presumably at highest risk for TB infection the group was labeled household contact No active TB cases have been reported among these residents for years

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None